dalteparin has been researched along with Esophageal Reflux in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dalteparin and warfarin treatment was started, and symptoms relieved rapidly." | 1.31 | Superior mesenteric and portal vein thrombosis following laparoscopic nissen fundoplication. ( Kemppainen, E; Kiviluoto, T; Kokkola, A; Sirén, J, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kemppainen, E | 1 |
| Kokkola, A | 1 |
| Sirén, J | 1 |
| Kiviluoto, T | 1 |
1 other study available for dalteparin and Esophageal Reflux
| Article | Year |
|---|---|
Superior mesenteric and portal vein thrombosis following laparoscopic nissen fundoplication.
Topics: Abdominal Pain; Anticoagulants; Dalteparin; Fundoplication; Gastroesophageal Reflux; Humans; Male; M | 2000 |